Management of pain and sedation in the intensive care unit

Advances in our approach to treating pain and sedation when caring for patients in the intensive care unit (ICU) have been propelled by decades of robust trial data, knowledge gained from patient experiences, and our evolving understanding of how pain and sedation strategies affect patient survival and long term outcomes. These data contribute to current practice guidelines prioritizing analgesia-first sedation strategies (analgosedation) that target light sedation when possible, use of short acting sedatives, and avoidance of benzodiazepines. Together, these strategies allow the patient to be more awake and able to participate in early mobilization and family interactions. The covid-19 pandemic introduced unique challenges in the ICU that affected delivery of best practices and patient outcomes. Compliance with best practices has not returned to pre-covid levels. After emerging from the pandemic and refocusing our attention on optimal pain and sedation management in the ICU, it is imperative to revisit the data that contributed to our current recommendations, review the importance of best practices on patient outcomes, and consider new strategies when advancing patient care.

Citation

Boncyk, C., Rolfsen, M. L., Richards, D., Stollings, J. L., Mart, M. F., Hughes, C. G., & Ely, E. W. (2024). Management of pain and sedation in the intensive care unit. BMJ (Clinical research ed.), 387, e079789. https://doi.org/10.1136/bmj-2024-079789

DOI

10.1136/bmj-2024-079789

URI

https://hdl.handle.net/20.500.14709/236